Koleli, IsilAstepe, Bahar Sariibrahim2024-08-042024-08-0420190937-34621433-3023https://doi.org/10.1007/s00192-019-03951-8https://hdl.handle.net/11616/98777Introduction and hypothesisThe International Consultation on Incontinence Questionnaire-Vaginal Symptoms (ICIQ-VS) was developed and validated in 2006 to evaluate vaginal symptoms, sexual matters, and quality of life of patients. This study aimed to validate the Turkish version of ICIQ-VS.MethodsThe English version of the questionnaire was translated into Turkish. On the basis of the pelvic organ prolapse quantification (POP-Q) system, symptomatic women with 2 grade pelvic organ prolapse (POP) were included in the symptomatic (patient) group and asymptomatic women with 1 grade POP in the asymptomatic (control) group. The questionnaire was administered three times: after the first examination of the women (T1), 3weeks after T1 (T2), and 3months after the POP surgery (T3).ResultsA total of 111 women were included in the study (symptomatic group, n=53; asymptomatic group, n=58). The missing data were ? 2%; the test-retest reliability was between 0.807 and 0.963, and the differences between the symptomatic and asymptomatic women were significant (p ? 0.001). A significant positive correlation existed between POP-Q and the vaginal symptom score, sexual matter score, and quality-of-life score (r(s)=0.844, 0.393, and 0.698, respectively; p<0.001). The Cronbach's alpha was 0.72 for the vaginal symptom score and 0.73 for the sexual matter score. The sensitivity to change was significant (p ? 0.05). The effect size values of the vaginal symptom score, sexual matter score, and quality-of-life score were 2.55, 2.33, and 1.56, respectively.ConclusionThe Turkish version of ICIQ-VS was successfully validated in this study, and a newer version of the questionnaire was made available for assessing vaginal symptoms, sexual matters, and quality of life of patients with POP.eninfo:eu-repo/semantics/closedAccessICIQ-VSPelvic organ prolapseQuality of lifeSexual mattersTurkish validationVaginal symptomsArticle307120312093103741410.1007/s00192-019-03951-82-s2.0-85065183365Q1WOS:000472492600024Q3